SLN
Silence Therapeutics
SLN
SLN
34 hedge funds and large institutions have $345M invested in Silence Therapeutics in 2023 Q4 according to their latest regulatory filings, with 8 funds opening new positions, 9 increasing their positions, 6 reducing their positions, and 2 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding in top 10
Funds holding in top 10: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
21% more funds holding
Funds holding: 28 → 34 (+6)
0.82% more ownership
Funds ownership: 18.29% → 19.11% (+0.82%)
Holders
34
Holding in Top 10
6
Calls
–
Puts
–
Top Buyers
| 1 | +$8.86M | |
| 2 | +$8.69M | |
| 3 | +$6.95M | |
| 4 |
LOAME
Lombard Odier Asset Management (Europe)
London,
United Kingdom
|
+$2.93M |
| 5 |
Morgan Stanley
New York
|
+$1.26M |
Top Sellers
| 1 | -$4.67M | |
| 2 | -$2.62M | |
| 3 | -$2.51M | |
| 4 |
WP
Woodline Partners
San Francisco,
California
|
-$2.04M |
| 5 |
CF
Cantor Fitzgerald
New York
|
-$372K |